The #ARLGnetwork RADICAL study investigated a simplified test that measures a patient’s gene activity to rapidly determine whether an illness is bacterial or viral, helping to prevent the overuse of antibiotics & decrease antibiotic resistance. Learn more: duke.is/ARLG-RADICAL
0
0
0
48
New in @CIDJournal: #ARLGnetwork researchers developed an anaerobic activity index that assigns numeric scores to common antibiotics. The AAI may be used as a research tool to evaluate the impact of anti-anaerobic antibiotics on patient outcomes🔗 duke.is/ARLG-publicati…
0
0
0
62
🎉 Study Milestone: Manuscript accepted for DIFFR, led by #ARLGnetwork mentee Sixto Manuel Leal, Jr., MD, PhD. The study evaluated a novel molecular diagnostic approach to detect Clostridioides difficile mRNA in stool. Learn more about ARLG studies🔗arlg.org/arlg-studies
0
0
1
61
📢 Check your email for an invitation to the #ARLGnetwork Grand Rounds on Friday, Nov. 6, 4-5 pm ET: Modern Management of MDROs – What Has Changed and What Hasn't? Presented by Susan Huang, MD, MPH, @UCIrvineHealth and moderated by Sarah Doernberg, MD, MAS, FIDSA, @UCSFHospitals.
0
1
3
126
An #ARLGnetwork MDRO study in @BioMedCentral Infectious Diseases found distinct molecular patterns & poor outcomes in carbapenem-resistant gram-negative infections, underscoring the importance of #AMR surveillance, collaboration, & future studies 🔗 duke.is/ARLG-publicati…
0
0
0
64
📢 New #ARLGNetwork MASTERMIND-RING results at #IDWeek2026: On Saturday, Oct. 24 at 2:30 pm ET, Michael Satlin, MD, will present findings on assays to predict ciprofloxacin resistance in Neisseria gonorrhoeae. View a list of ARLG member presentations🔗arlg.org/id-week-2026
0
0
0
93
📢 New #ARLGNetwork MASTERMIND-Pneumonia study results at #IDWeek2026: On Thurs., Oct. 22, 12:15 pm ET, Kimberly Hanson, MD, MHS, will present findings on novel tests for diagnosing ventilator-associated pneumonia. View a list of ARLG member presentations🔗arlg.org/id-week-2026
0
0
1
91
Next week at #IDWeek2026: #ARLGnetwork Trialist in Training Pranita Tamma, MD, MHS, will deliver the Caroline B. Hall Lecture, “Antimicrobial Resistance: The Next Pandemic Is Already Here,” on Oct. 22 at 3:15 pm ET. See a list of ARLG member presentations🔗arlg.org/id-week-2026
0
0
2
109
An #ARLGnetwork scoping review in @npjAMR maps low-cost approaches for detecting #AMR in bacterial infections in resource-limited settings & proposes the REACH checklist to strengthen reporting across AMR diagnostic development🔗duke.is/ARLG-publicati…
0
0
0
77
✅Enrollment is complete for MASTERMIND-RING, an #ARLGnetwork study evaluating investigational reflex tests to detect genetic markers that predict ciprofloxacin resistance or susceptibility in Neisseria gonorrhoeae. Learn more about ARLG studies🔗arlg.org/arlg-studies
0
0
1
74
A global #ARLGnetwork POP study in @JIDJournal found reduced susceptibility to cefiderocol is present worldwide, raising concerns about its use as a last resort antibiotic for patients with carbapenem-resistant P. aeruginosa infections🔗duke.is/ARLG-publicati…
0
0
0
62
📰ICYMI: The latest #ARLGnetwork newsletter is on our website. Read about ARLG Co-PI Dr. Vance Fowler’s @ISAC_world award, recent research in @JAMAnetwork and @OFIDJournal, clinical trial site and member spotlights, and more network news: arlg.org/august-2026
#AMR #IDTwitter
#AMR #IDTwitter
0
0
1
111
In this #ARLGnetwork spotlight, Thomas Holland, MD, MSc-GH, @DukeMedSchool reflects on 14 years with ARLG & shares what drives his work in #AMR. As a PI, mentor, & Gram-Positive Committee Chair, he’s making important contributions to the ARLG 🔗 arlg.org/thomas-holland…
0
0
2
68
The #ARLGnetwork FAST trial evaluated rapid vs. standard antimicrobial susceptibility testing for gram-negative bloodstream infections. Read the results and check out the highlights in a @JAMANetwork editorial, podcast, and research summary🔗arlg.org/fast-jama
0
1
3
120
✅Study Milestone: Enrollment has closed for #ARLGnetwork OPTIMIZE-GNI, a Phase IV study of cystatin C–guided beta-lactam dosing in critically ill adults with suspected or documented #AMR Gram-negative infections. Learn more about ARLG research🔗arlg.org/arlg-studies
0
0
0
98
▶️The #ARLGnetwork Innovations in Diagnostic Trials recording is now available! Presented by Drs. Michael Satlin @WeillCornell, Sarah Doernberg @UCSFHospitals & Ritu Banerjee @VUMCDiscoveries & moderated by Dr. Robin Patel @MayoClinic🔗arlg.org/grand-rounds-d…
0
0
0
60
In this #ARLGnetwork member spotlight, Sarah Doernberg, MD, MAS, @UCSF, a longtime ARLG investigator & mentor, shares how her work in diagnostics, treatment, antimicrobial stewardship, & patient-reported outcomes supports the fight against #AMR🔗arlg.org/sarah-doernber…
0
0
2
153
How can RCTs better reflect what matters most to patients? An editorial in @OFIDJournal highlights the #ARLGnetwork’s application of the Desirability of Outcome Ranking (DOOR) framework to trials in acute bacterial skin and skin structure infections🔗 arlg.org/door-absssi-of…
0
0
0
93
An #ARLGnetwork study in @OFIDJournal applies the DOOR method to trials in acute bacterial skin and skin structure infections (ABSSSI), offering a patient-centered benefit-risk framework that may add perspective beyond traditional clinical outcomes🔗duke.is/ARLG-publicati…
0
0
0
82
How do patients and clinicians describe the impact of complicated UTIs on quality of life? An #ARLGnetwork study in @JAMANetworkOpen highlights gaps that could inform patient-centered trial outcomes & improve patient-clinician communication🔗duke.is/ARLG-publicati…
0
0
1
84